ISO/TR 12417-2:2022
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
Cardiovascular implants and extracorporeal systems — Vascular device-drug combination products — Part 2: Local regulatory information
This document provides region-specific information for:
—??? local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
—??? changes related to the drug-containing part and how they are evaluated by different local regions.
For implanted products, this document is considered as a supplement to ISO?14630, which specifies general requirements for the performance of non-active surgical implants.
This document is considered also as a supplement to ISO?12417-1, and any relevant device-specific standards, such as the ISO?25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.
| Edition | 2022 |
|---|---|
| Standard Part No | 2 |
| Published Date | 2022 |
| Published By | International Standardization Organisation/Technical Reference |
| Page Count | 29 |